BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12657873)

  • 1. Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding.
    Ho AM; Dion PW; Karmakar MK
    Anesthesiology; 2003 Apr; 98(4):1025-6; author reply 1026-7. PubMed ID: 12657873
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient.
    Holcomb JB; Hoots K; Moore FA
    Mil Med; 2005 Apr; 170(4):287-90. PubMed ID: 15916295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
    Udy A; Vaghela M; Lawton G; Sigston P
    Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings of the 6th Novo Nordisk Symposium on Treatment of Bleeding and Thrombotic Disorders. Copenhagen, Denmark, May 3-4, 2001.
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):1-50. PubMed ID: 11840984
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant activated factor VII: panacea or passing fad?
    Parker RI
    Pediatr Crit Care Med; 2005 May; 6(3):379-80. PubMed ID: 15880015
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.
    Chuansumrit A; Nuntnarumit P; Okascharoen C; Teeraratkul S; Suwansingh S; Supapannachart S
    Pediatrics; 2002 Jul; 110(1 Pt 1):169-71. PubMed ID: 12093965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging off-label uses for recombinant activated factor VII: grading the evidence.
    Enomoto TM; Thorborg P
    Crit Care Clin; 2005 Jul; 21(3):611-32. PubMed ID: 15992675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive transfusion coagulopathy.
    Levy JH
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S59-63. PubMed ID: 16427387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
    Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
    Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of recombinant activated factor VII in the management of life-threatening coagulopathic bleeding.
    Gibbs N
    Anaesth Intensive Care; 2005 Apr; 33(2):163-4. PubMed ID: 15960396
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of recombinant factor VIIa in liver diseases.
    Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant factor VIIa in infants with severe coagulopathy.
    Fontaine MJ; Lazarchick J; Taylor S; Annibale D
    J Perinatol; 2004 May; 24(5):310-1. PubMed ID: 15116125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant activated factor VII to arrest uncontrolled bleeding: a case series.
    Alsayegh F; Fakeir A; Alhumood S; Abdumalek K; Matar H; Samaul I; Nampoory N; Kabalawi H; Mousa SA
    Clin Appl Thromb Hemost; 2009; 15(2):225-32. PubMed ID: 18160562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation management in massive bleeding.
    Griffee MJ; Deloughery TG; Thorborg PA
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.